Type 1 diabetes (T1D) arises from the autoimmune destruction of the insulin-secreting beta cells of the pancreas resulting in complete dependence on exogenously administered insulin for survival. Twin studies indicate that susceptibility to T1D is, in part, genetically determined, but within families the disorder follows no clear mode of inheritance and is generally thought to result from the combined effects of multiple genes interacting with non-genetic factors. The extended pre-clinical period in T1D provides an excellent window to intervene in the autoimmune phase of pathogenesis with the goal of preventing the onset of frank disease. Identification of susceptibility genes provides opportunities for novel therapeutic interventions targeting their products and the biochemical pathways they impact, as well as for disease prediction that is crucial in defining populations in which therapies can be tested. Two genomic regions are generally agreed upon as containing susceptibility loci for T1D, the HLA region on 6p (IDDM1) and the insulin gene (INS) region on 1 1p (IDDM2). In order to identify additional loci that contribute to T1D pathogenesis, we have genome scanned a total of 412 T1D multiplex families of US origin, added data from 355 comparable UK T1D families, and carried out a joint analysis of the evidence for linkage to T1D. These studies provide significant evidence of linkage at 3 sites and suggestive evidence for 4 more. In this application we focus on the two regions that we judge the most promising from our linkage studies, 16q22-24, where the evidence of linkage is the most highly significant, and 10q25, where there is confirmation of linkage from independent studies. We have identified multiple markers with alleles in significant linkage disequilibrium with T1D in both of these regions. In the current application, we pursue these findings through comprehensive linkage disequilibrium mapping, characterization of all transcription units in the regions and functional studies of the relevant genes and their products. Our long-term goal is to define the genetic contributions to T1D pathogenesis and use this information to develop novel tools for prediction and prevention of T1D. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046635-12
Application #
6890450
Study Section
Epidemiology of Chronic Diseases Study Section (ECD)
Program Officer
Akolkar, Beena
Project Start
1993-05-01
Project End
2009-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
12
Fiscal Year
2005
Total Cost
$412,425
Indirect Cost
Name
Benaroya Research Institute at Virginia Mason
Department
Type
DUNS #
076647908
City
Seattle
State
WA
Country
United States
Zip Code
98101
Gorman, Jacquelyn A; Hundhausen, Christian; Errett, John S et al. (2017) The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity. Nat Immunol 18:744-752
Ge, Yan; Paisie, Taylor K; Newman, Jeremy R B et al. (2017) UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-?B Signaling. Diabetes 66:2033-2043
Ge, Yan; Onengut-Gumuscu, Suna; Quinlan, Aaron R et al. (2016) Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes. Diabetes 65:794-802
Onengut-Gumuscu, Suna; Chen, Wei-Min; Burren, Oliver et al. (2015) Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet 47:381-6
Evangelou, Marina; Smyth, Deborah J; Fortune, Mary D et al. (2014) A method for gene-based pathway analysis using genomewide association study summary statistics reveals nine new type 1 diabetes associations. Genet Epidemiol 38:661-70
Fløyel, Tina; Brorsson, Caroline; Nielsen, Lotte B et al. (2014) CTSH regulates ?-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci U S A 111:10305-10
Tomlinson 4th, M Joseph; Pitsillides, Achilleas; Pickin, Rebecca et al. (2014) Fine mapping and functional studies of risk variants for type 1 diabetes at chromosome 16p13.13. Diabetes 63:4360-8
Howson, Joanna M M; Cooper, Jason D; Smyth, Deborah J et al. (2012) Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes. Diabetes 61:3012-7
Evanko, Stephen P; Potter-Perigo, Susan; Bollyky, Paul L et al. (2012) Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol 31:90-100
Bollyky, Paul L; Bogdani, Marika; Bollyky, Jennifer B et al. (2012) The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep 12:471-80

Showing the most recent 10 out of 41 publications